[ad_1]
An Alaskan health worker developed a severe allergic reaction after receiving the Pfizer vaccine for the coronavirus, the New York Times reported, citing three people who have learned of the person’s health.
The allergic reaction occurred on Tuesday and this person is in stable condition after being admitted to the hospital.
According to the report, it has not been clarified whether the vaccinated person had a history of allergic reactions.
Pfizer has not commented on this information.
The FDA has recommended that people with allergies consult their doctors before receiving the vaccine to see if they are allergic to any ingredient in the vaccine.
Earlier this month, the British OAS announced that those with a history of drug or food anaphylaxis should not receive the Pfizer-BioNTech vaccine.
Washington Works with Pfizer to Address ‘Challenges’ in Vaccine Production
US authorities are working with Pfizer Inc. to help maximize production of the Covid-19 vaccine, after the pharmaceutical company announced that it could face “challenges” in its production, US Health Secretary Alex said today. Random.
Pfizer did not respond to a request for comment. Earlier this week, however, Albert Burla, the company’s chief executive, told CNBC that he had asked the US government to use the Defense Production Act to remove some critical “supply restrictions”, especially in some components. . However, it did not elaborate on possible shortcomings.
US officials did not specify what the specific “challenges” to the production were. However, they said they know the materials and equipment necessary for the production of vaccines, from the experience they have from their cooperation with other pharmaceutical companies.
“They have recently informed us about the various challenges they may face in production and we will ensure that, through whatever mechanism is necessary, we will provide our full support to ensure production for the American people,” Azar said.
At the same telephone press conference, Dr Moncef Sloui, US Operation Speed Vortex advisor, said that the US government was in talks with Pfizer to secure an additional 100 million doses of your vaccine.
Earlier, officials said the United States had already signed contracts to buy 300 million doses of Pfizer / BioNTech and Moderna and a total of 900 million doses from pharmaceutical companies that develop vaccines for Covid-19. They added that the Moderna vaccine is likely to receive approval from authorities on Friday.
at google news and be the first to know all the news
[ad_2]
